Sector ratings Neurizon Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:04:21 20/05/2026 am IST			5-day change	1st Jan Change
0.0660 ^AUD	-2.94%		-4.35%	-22.35%

13/05	Neurizon Therapeutics receives ethics approval for Phase 1 Nuz-001 oral liquid formulation study	RE
13/05	Neurizon Therapeutics Gets Ethics Committee Nod for Neurodegenerative Disease Phase 1 Study; Shares Gain 3%	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility
NEURIZON THERAPEUTICS LIMITED	3.6Cr	-	-	-	-	-	-
ELI LILLY AND COMPANY	91TCr		A
JOHNSON & JOHNSON	55TCr		BBB
ABBVIE INC.	38TCr	-	AA	-		-
ROCHE HOLDING AG	33TCr		AA
ASTRAZENECA PLC	29TCr		A
NOVARTIS AG	29TCr		AAA
MERCK & CO., INC.	28TCr		A
NOVO NORDISK A/S	20TCr		A
AMGEN INC.	18TCr		A
GILEAD SCIENCES, INC.	16TCr		AA
PFIZER INC.	15TCr		A
BRISTOL-MYERS SQUIBB COMPANY	12TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	11TCr		AA
SANOFI	10TCr		AA
GSK PLC	10TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	8.21TCr		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.22TCr		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.02TCr		AA
BAYER AG	4.39TCr		AA
Average	21.91TCr		AA
Weighted average by Cap.			AA